Rigshospitalet
Atul Anand is a highly experienced researcher in the field of cancer biology, currently serving as a Postdoctoral Research Fellow at Rigshospitalet since April 2022, focusing on the roles of macrophages and microglia in the glioblastoma microenvironment, along with multi-omic and sc-seq analyses of glioblastoma-associated immune cells. Prior to this, Atul worked as a Postdoctoral Research Fellow at Odense University Hospital and as a Postdoctoral Researcher at Kræftens Bekæmpelse (Danish Cancer Society) from June 2014 to March 2019, alongside earlier roles as a Senior Research Associate at Bristol Myers Squibb-Biocon Research Center and a Senior Research Fellow at Tata Memorial Centre. Atul holds a PhD in Cancer Biology from the University of Copenhagen and possesses a strong educational background with multiple advanced degrees in Biotechnology and Immunology from respected institutions.
Rigshospitalet
Rigshospitalet is Denmark’s most highly specialised hospital, providing treatment for people in Denmark, the Faeroe Islands and Greenland. We stand for an open and inclusive hospital with focus on patient needs. Also we focus on being an efficient workplace promoting wellbeing for our approximately 12.000 employees. Through our skilful employees we are among the best in Europe; professionally and for training and research. On 1 January 2015 Rigshospitalet merged with Glostrup Hospital, making it the largest hospital in Denmark.